Argus Raises UnitedHealth Group (NYSE:UNH) Price Target to $650.00

UnitedHealth Group (NYSE:UNHGet Rating) had its price objective raised by Argus from $580.00 to $650.00 in a research report report published on Monday morning, The Fly reports. The firm currently has a buy rating on the healthcare conglomerate’s stock.

A number of other brokerages have also recently weighed in on UNH. Deutsche Bank Aktiengesellschaft increased their price target on shares of UnitedHealth Group from $549.00 to $556.00 in a research note on Tuesday, July 19th. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $613.00 to $612.00 and set an overweight rating for the company in a research note on Wednesday, May 25th. Credit Suisse Group upped their price objective on shares of UnitedHealth Group from $575.00 to $579.00 and gave the stock an outperform rating in a research report on Monday, July 18th. Royal Bank of Canada set a $563.00 price objective on shares of UnitedHealth Group and gave the stock an outperform rating in a research report on Monday, April 18th. Finally, Raymond James upped their price objective on shares of UnitedHealth Group from $540.00 to $620.00 and gave the stock a strong-buy rating in a research report on Tuesday, April 19th. Three analysts have rated the stock with a hold rating, sixteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of Moderate Buy and a consensus target price of $582.50.

UnitedHealth Group Trading Up 0.6 %

Shares of UnitedHealth Group stock opened at $534.61 on Monday. The company has a fifty day simple moving average of $500.41 and a 200-day simple moving average of $496.04. UnitedHealth Group has a 12-month low of $383.12 and a 12-month high of $553.29. The company has a current ratio of 0.77, a quick ratio of 0.78 and a debt-to-equity ratio of 0.60. The stock has a market cap of $501.56 billion, a price-to-earnings ratio of 27.92, a PEG ratio of 1.64 and a beta of 0.77.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.24 by $0.33. The business had revenue of $80.33 billion during the quarter, compared to analysts’ expectations of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The company’s revenue for the quarter was up 12.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $4.70 EPS. On average, equities analysts forecast that UnitedHealth Group will post 21.84 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 28th. Shareholders of record on Monday, June 20th were issued a dividend of $1.65 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.45. This represents a $6.60 annualized dividend and a yield of 1.23%. The ex-dividend date was Thursday, June 16th. UnitedHealth Group’s dividend payout ratio (DPR) is 34.46%.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction dated Thursday, May 19th. The shares were sold at an average price of $478.96, for a total transaction of $1,197,400.00. Following the sale, the director now directly owns 1,215,000 shares of the company’s stock, valued at approximately $581,936,400. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO Andrew Witty sold 11,376 shares of the firm’s stock in a transaction that occurred on Monday, July 18th. The shares were sold at an average price of $527.90, for a total value of $6,005,390.40. Following the sale, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at $40,415,496.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction that occurred on Thursday, May 19th. The stock was sold at an average price of $478.96, for a total transaction of $1,197,400.00. Following the completion of the sale, the director now directly owns 1,215,000 shares in the company, valued at $581,936,400. The disclosure for this sale can be found here. Insiders have sold 17,649 shares of company stock valued at $9,071,142 in the last ninety days. Insiders own 0.40% of the company’s stock.

Institutional Investors Weigh In On UnitedHealth Group

Hedge funds have recently modified their holdings of the stock. Outfitter Financial LLC acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $25,000. Urban Wealth Management LLC purchased a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $29,000. Advocacy Wealth Management Services LLC raised its stake in shares of UnitedHealth Group by 75.8% during the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 25 shares during the period. Cascade Investment Advisors Inc. raised its stake in shares of UnitedHealth Group by 100.0% during the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 30 shares during the period. Finally, Rothschild & Co Wealth Management UK Ltd purchased a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $31,000. 87.48% of the stock is owned by institutional investors and hedge funds.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Read More

The Fly logo

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.